Shweta Singh
Research Subjects
Research Interests
Shweta Singh has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Nikesh Sinha
VRDL Department of Microbiology, Rajendra Institute of Medical Sciences, Ranchi, Jharkhand
3 shared publications - Shashank Nand Tiwari
Department of Microbiology, All India Institute of Medical Sciences, Deoghar-814152, Jharkhand, India
2 shared publications Manoj Kumar
1 shared publication- Manoj Kumar
101_ Department of Chemistry, University of Rajasthan, 302004, Jaipur, India
1 shared publication Manoj Kumar Shashank Nand Tiwari
1 shared publication
Latest Publications
- 10 February 2022
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 11 (2) , 270-274
An Outbreak Study of Scrub Typhus in Latehar District of Jharkhand
Background and Objectives: Scrub typhus, a zoonotic disease has become a public health problem in many parts of world. It is an arthropod borne gram-negative obligate intracellular bacillus Orientia tsutsugamushi. Aim & objective: We reported in this study a recent outbreak of scrub typhus from Barwadih block of Latehar district, of Jharkhand. Materials and Methods: Samples of clinically suspected cases of scrub typhus (collected by both active and passive surveillance), were tested by IgM ELISA and also Real Time PCR in the Department of Microbiology, RIMS, Ranchi. Results: During the study period, a total of 67 samples from clinically suspected cases of scrub typhus were tested, out of which 16 samples were positive. Conclusion: The increase in scrub typhus infection, prompts us for a better prevention and management of the disease, so as to combat the complications caused by scrub typhus.
- 10 February 2022
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 11 (2) , 270-274
An Outbreak Study of Scrub Typhus in Latehar District of Jharkhand
Background and Objectives: Scrub typhus, a zoonotic disease has become a public health problem in many parts of world. It is an arthropod borne gram-negative obligate intracellular bacillus Orientia tsutsugamushi. Aim & objective: We reported in this study a recent outbreak of scrub typhus from Barwadih block of Latehar district, of Jharkhand. Materials and Methods: Samples of clinically suspected cases of scrub typhus (collected by both active and passive surveillance), were tested by IgM ELISA and also Real Time PCR in the Department of Microbiology, RIMS, Ranchi. Results: During the study period, a total of 67 samples from clinically suspected cases of scrub typhus were tested, out of which 16 samples were positive. Conclusion: The increase in scrub typhus infection, prompts us for a better prevention and management of the disease, so as to combat the complications caused by scrub typhus.
- Open Access
- 10 February 2022
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 11 (2) , 264-269
Cytomegalovirus Infection Burden Among Patients Attending a Tertiary Care Hospital in Jharkhand
Cytomegalovirus (CMV) is a herpes virus that causes severe illness and death in people who are immunocompromised, including organ and bone marrow transplant recipients, HIV infected people, those on immunosuppressive drugs and newborns infected during pregnancy. Aim: To estimate the disease burden of Cytomegalovirus infection among the patients attending Rajendra Institute of Medical Sciences. Samples of clinically suspected cases of cytomegalovirus infection from all the age groups were collected and sent to the Department of Microbiology, RIMS, Ranchi, from January 2021 to December 2021. The samples were tested for IgM by ELISA. Results: During the study period, a total of 618 samples from clinically suspected cases were received for testing out of which, 67 samples tested positive. Of the total positive cases, 41 were males and 26 were females. Conclusion: Anti-CMV drugs are available now-a- days for the treatment of severe infections in immunosuppressed patients. Developments of vaccine to protect pregnant women from primary infection are in progress.
- 10 February 2022
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 11 (2) , 264-269
Open AccessCytomegalovirus Infection Burden Among Patients Attending a Tertiary Care Hospital in Jharkhand
Cytomegalovirus (CMV) is a herpes virus that causes severe illness and death in people who are immunocompromised, including organ and bone marrow transplant recipients, HIV infected people, those on immunosuppressive drugs and newborns infected during pregnancy. Aim: To estimate the disease burden of Cytomegalovirus infection among the patients attending Rajendra Institute of Medical Sciences. Samples of clinically suspected cases of cytomegalovirus infection from all the age groups were collected and sent to the Department of Microbiology, RIMS, Ranchi, from January 2021 to December 2021. The samples were tested for IgM by ELISA. Results: During the study period, a total of 618 samples from clinically suspected cases were received for testing out of which, 67 samples tested positive. Of the total positive cases, 41 were males and 26 were females. Conclusion: Anti-CMV drugs are available now-a- days for the treatment of severe infections in immunosuppressed patients. Developments of vaccine to protect pregnant women from primary infection are in progress.
- 20 January 2022
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 11 (1) , 219-223
Disease Burden of Herpes Simplex Virus among Patients Attending Rajendra Institute of Medical Sciences, Ranchi, Jharkhand
HSV-1 has been associated with oro-labial disease, with most infections occurring during childhood, and HSV-2 with genital disease. Additionally, HSV-2 likely contributes substantially to the spread of HIV infection. To estimate the disease burden of Herpes Simplex Virus among the patients attending Rajendra Institute of Medical Sciences. Samples of clinically suspected cases of herpes simplex virus received in the Department of Microbiology, RIMS, Ranchi, from January 2020 to December 2021 were included in the study. Results: During the study period, a total of 1737 samples from clinically suspected cases of herpes simplex virus were received for testing. Of these 1737 samples, 150 samples tested positive for herpes simplex virus. Of total suspected cases, 935 were males and 802 were females. The global burden of HSV-2 infection is large, causing increased risk of genital ulcer disease, HIV acquisition, and transmission of HSV-2 to partners or neonates. These estimates highlight the critical need for development of vaccines, and other new HSV prevention strategies.
- 20 January 2022
- Published by Excellent Publishers in International Journal of Current Microbiology and Applied Sciences
- Vol. 11 (1) , 219-223
Disease Burden of Herpes Simplex Virus among Patients Attending Rajendra Institute of Medical Sciences, Ranchi, Jharkhand
HSV-1 has been associated with oro-labial disease, with most infections occurring during childhood, and HSV-2 with genital disease. Additionally, HSV-2 likely contributes substantially to the spread of HIV infection. To estimate the disease burden of Herpes Simplex Virus among the patients attending Rajendra Institute of Medical Sciences. Samples of clinically suspected cases of herpes simplex virus received in the Department of Microbiology, RIMS, Ranchi, from January 2020 to December 2021 were included in the study. Results: During the study period, a total of 1737 samples from clinically suspected cases of herpes simplex virus were received for testing. Of these 1737 samples, 150 samples tested positive for herpes simplex virus. Of total suspected cases, 935 were males and 802 were females. The global burden of HSV-2 infection is large, causing increased risk of genital ulcer disease, HIV acquisition, and transmission of HSV-2 to partners or neonates. These estimates highlight the critical need for development of vaccines, and other new HSV prevention strategies.